Irish pharma firm Amryt nears approval for butterfly skin treatment
EMA has 67 days to decide whether to back recommendation of its expert committee
EMA has 67 days to decide whether to back recommendation of its expert committee
Dublin-based biopharma group says most of the funds to be used to repay existing loan
Rare disease specialist says performance was ‘strong’ in ‘extremely busy’ period
Company upgrades forecasts as it completes Chiasma takeover
Drug group expands its portfolio of medicines while reporting first-quarter numbers
Group plots dual Nasdaq listing to create enlarged rare disease company
Lojuxta revenues driven by UK, France reimbursement approval
Biopharma firm signs new deal for gene therapy that could treat genetic condition EB
Latest deal is fourth in three months for Ierish biopharmaceutical company
Licence agreement said to cover €8m of annualised sales in Europe and Middle East
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices